Moutaz Derbala

Summary

Publications

  1. doi Viral kinetic of HCV genotype-4 during pegylated interferon alpha 2a: ribavirin therapy
    M F Derbala
    Department of Gastroenterology and Hepatology, Hamad Medical Corporation, Doha, Qatar
    J Viral Hepat 15:591-9. 2008
  2. ncbi Pegylated interferon-alpha 2b-ribavirin combination in Egyptian patients with genotype 4 chronic hepatitis
    M Derbala
    Department of Gastroenterology, Hamad Medical Corporation, Doha, Qatar
    J Viral Hepat 12:380-5. 2005
  3. pmc Microalbuminuria in hepatitis C-genotype 4: effect of pegylated interferon and ribavirin
    Moutaz Derbala
    Department of Gastroenterology and Hepatology, Hamad Medical Corporation, PO Box 3050, Doha, 00974, State of Qatar
    World J Gastroenterol 16:1226-31. 2010
  4. pmc Hepatitis C virus genotype 4 with normal transaminases: histological changes, schistosomiasis and response to treatment
    M F Derbala
    Department of Gastroenterology and Hepatology, Hamad Hospital and Weill Cornell Medical College in Qatar, Egypt
    J Viral Hepat 18:e258-62. 2011
  5. doi The predictive value of IL28B rs12979860, rs11881222 and rs8099917 polymorphisms and IP-10 in the therapeutic response of Egyptian genotype 4 patients
    Moutaz Derbala
    Gastroenterology and Hepatology Department, Hamad Hospital, Doha, Qatar
    Virology 444:292-300. 2013
  6. pmc Interleukin-28 and hepatitis C virus genotype-4: treatment-induced clearance and liver fibrosis
    Moutaz Derbala
    Department of Gastroenterology and Hepatology, Hamad Hospital, Doha 3050, Qatar
    World J Gastroenterol 18:7003-8. 2012
  7. ncbi Myalgia during interferon therapy--does it warrant monitoring muscle enzymes?
    Anil John
    Department of Gastroenterology, Medical Research Centre, Hamad Medical Corporation, Doha, Qatar
    Trop Gastroenterol 30:175-6. 2009
  8. pmc Aspartate transaminase to platelet ratio index in hepatitis C virus and Schistosomiasis coinfection
    Moutaz Derbala
    Moutaz Derbala, Mohammed Elshiekh Elbadri, Saad Alkaabi, Khaleel Hassan Sultan, Yasser Medhat Kamel, Gastroenterology and Hepatology, Hamad Medical Corporation, Hamad General Hospital, Doha 00974, Qatar
    World J Gastroenterol 21:13132-9. 2015
  9. doi Does emerging Clarithromycin resistance signal an obituary to empirical standard triple therapy for Helicobacter pylori infection?
    Anil John
    Department of Gastroenterology, Hamad Medical Corporation, Doha, Qatar
    Indian J Gastroenterol 34:404-7. 2015
  10. doi Neutropenia and viral load decline during treatment of hepatitis C virus genotype-4
    Aliaa Amer
    Hamad Medical Corporation, Laboratory Medicine and Histopathology, Hematology Section, Doha, Qatar
    Turk J Gastroenterol 25:15-9. 2014

Collaborators

  • Fatma M Shebl
  • A Bener
  • Anil John
  • Aliaa Amer
  • Sanjay Doiphode
  • Saad Al Kaabi
  • Manik Sharma
  • Prem Chandra
  • Ragesh Babu
  • Rafie Yacoub
  • Kaabi Saad Al
  • Rafie Yakoub
  • Anjum S John
  • Rajvir Singh

Detail Information

Publications10

  1. doi Viral kinetic of HCV genotype-4 during pegylated interferon alpha 2a: ribavirin therapy
    M F Derbala
    Department of Gastroenterology and Hepatology, Hamad Medical Corporation, Doha, Qatar
    J Viral Hepat 15:591-9. 2008
    ..Those unfortunate cases who do not achieve viral clearance by week 1 or week 4 should not be deprived from the treatment but rather given more time till week 12 before being classified as non-responders...
  2. ncbi Pegylated interferon-alpha 2b-ribavirin combination in Egyptian patients with genotype 4 chronic hepatitis
    M Derbala
    Department of Gastroenterology, Hamad Medical Corporation, Doha, Qatar
    J Viral Hepat 12:380-5. 2005
    ....
  3. pmc Microalbuminuria in hepatitis C-genotype 4: effect of pegylated interferon and ribavirin
    Moutaz Derbala
    Department of Gastroenterology and Hepatology, Hamad Medical Corporation, PO Box 3050, Doha, 00974, State of Qatar
    World J Gastroenterol 16:1226-31. 2010
    ....
  4. pmc Hepatitis C virus genotype 4 with normal transaminases: histological changes, schistosomiasis and response to treatment
    M F Derbala
    Department of Gastroenterology and Hepatology, Hamad Hospital and Weill Cornell Medical College in Qatar, Egypt
    J Viral Hepat 18:e258-62. 2011
    ..Severe fibrosis is a strong and independent predictor of response to treatment. Therefore, it is important to treat individuals with PNALT levels regardless of schistosomiasis...
  5. doi The predictive value of IL28B rs12979860, rs11881222 and rs8099917 polymorphisms and IP-10 in the therapeutic response of Egyptian genotype 4 patients
    Moutaz Derbala
    Gastroenterology and Hepatology Department, Hamad Hospital, Doha, Qatar
    Virology 444:292-300. 2013
    ..Interleukin-28B (IL28B) polymorphisms have previously been reported to be strongly associated with spontaneous and treatment-induced HCV viral clearance...
  6. pmc Interleukin-28 and hepatitis C virus genotype-4: treatment-induced clearance and liver fibrosis
    Moutaz Derbala
    Department of Gastroenterology and Hepatology, Hamad Hospital, Doha 3050, Qatar
    World J Gastroenterol 18:7003-8. 2012
    ..To investigate the association between interleukin-28B (IL28B) genotype and response to treatment and hepatic fibrosis in patients with hepatitis C virus (HCV) genotype 4...
  7. ncbi Myalgia during interferon therapy--does it warrant monitoring muscle enzymes?
    Anil John
    Department of Gastroenterology, Medical Research Centre, Hamad Medical Corporation, Doha, Qatar
    Trop Gastroenterol 30:175-6. 2009
    ..This excluded the possibility of subclinical myositis in myalgic patients and thus led us to conclude that routine monitoring of muscles enzymes is neither necessary nor beneficial...
  8. pmc Aspartate transaminase to platelet ratio index in hepatitis C virus and Schistosomiasis coinfection
    Moutaz Derbala
    Moutaz Derbala, Mohammed Elshiekh Elbadri, Saad Alkaabi, Khaleel Hassan Sultan, Yasser Medhat Kamel, Gastroenterology and Hepatology, Hamad Medical Corporation, Hamad General Hospital, Doha 00974, Qatar
    World J Gastroenterol 21:13132-9. 2015
    ..To assess the diagnostic accuracy, of aminotransferase-to-platelet ratio index (APRI) alone and with antischistosomal antibody (Ab) in patients with hepatitis C virus (HCV) and schistosomiasis coinfection...
  9. doi Does emerging Clarithromycin resistance signal an obituary to empirical standard triple therapy for Helicobacter pylori infection?
    Anil John
    Department of Gastroenterology, Hamad Medical Corporation, Doha, Qatar
    Indian J Gastroenterol 34:404-7. 2015
    ..We need to abandon empirical and blind triple therapy without post-treatment testing and devise alternate effective treatment strategies against H. pylori based on the local resistance patterns observed...
  10. doi Neutropenia and viral load decline during treatment of hepatitis C virus genotype-4
    Aliaa Amer
    Hamad Medical Corporation, Laboratory Medicine and Histopathology, Hematology Section, Doha, Qatar
    Turk J Gastroenterol 25:15-9. 2014
    ..We studied the relationship between early viral clearance in response to treatment, and neutrophil count and fall in neutrophils in HCV-genotype 4 patients...